Insider Trading25 Jun 2026, 12:38 pm
Mangalam Drugs Closes Trading Window for Q1 FY27 Results
AI Summary
Mangalam Drugs & Organics Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code. The trading window will be shut from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the period ending June 30, 2026. This measure is standard practice to prevent potential insider trading before the official announcement of financial performance.
Key Highlights
- Trading window closed for designated persons from July 1, 2026.
- Closure is for the period ending June 30, 2026.
- Effective until 48 hours post financial results declaration.
- Aims to prevent insider trading activities.
- Complies with SEBI regulations and company policy.
Price Impact
More from MANGALAM